An Interview with Carl June, MD, a Pioneer in CAR T-cell Therapy
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
Category: Research
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
The prognosis for a patient with cancer depends on several factors, including the cancer’s stage. Patients whose cancers are diagnosed at earlier...
In January, when most of us in the United States were busy living the hustle and bustle of everyday life, one shrewd virologist and computer biologist saw...
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
The AACR Virtual Meeting: COVID-19 and Cancer opened Monday with a keynote address from the nation’s leading infectious disease expert, Anthony Fauci, MD, the director of the National Institutes of Allergy and Infectious Diseases. Well...
“Progress in science depends on new techniques, new discoveries, and new ideas— probably in that order,” said the late Nobel Laureate...
The COVID-19 pandemic remains at the center of health and science news as cases of the disease continue to rise...
AACR Virtual Annual Meeting II featured more than 20 minisymposia sessions during the three-day conference. One such minisymposium focused on Infection and...